Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

JA Bioservice ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.5% 8.2% 7.1% 10.4% 7.0% 9.7% 17.5% 17.3%   Credit score (0-100)   43 31 34 22 34 24 9 9   Credit rating   BBB BB BBB BB BBB BB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   852 705 594 725 602 492 0.0 0.0   EBITDA   143 63.6 -34.8 88.7 -1.2 -84.5 0.0 0.0   EBIT   118 38.6 -45.7 72.2 -17.6 -101 0.0 0.0   Pre-tax profit (PTP)   112.1 30.4 -49.7 68.9 -22.9 -81.7 0.0 0.0   Net earnings   83.8 19.0 -33.7 52.1 -22.9 -57.7 0.0 0.0   Pre-tax profit without non-rec. items   112 30.4 -49.7 68.9 -22.9 -81.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   31.3 6.3 71.3 54.8 38.4 22.0 0.0 0.0   Shareholders equity total   139 78.4 44.6 96.8 73.8 16.1 -33.9 -33.9   Interest-bearing liabilities   48.7 25.9 0.0 0.0 0.0 0.0 33.9 33.9   Balance sheet total (assets)   339 188 187 167 124 114 0.0 0.0   Net Debt   -164 -111 -38.1 -75.0 -35.6 -34.5 33.9 33.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   852 705 594 725 602 492 0.0 0.0   Gross profit growth   14.7% -17.2% -15.8% 22.0% -17.0% -18.2% -100.0% 0.0%   Employees   0 0 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   339 188 187 167 124 114 0 0   Balance sheet change%   8.2% -44.5% -0.6% -11.0% -25.3% -8.1% -100.0% 0.0%   Added value   143.3 63.6 -34.8 88.7 -1.2 -84.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -50 -50 54 -33 -33 -33 -22 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.9% 5.5% -7.7% 10.0% -2.9% -20.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.4% 14.6% -24.3% 40.8% -12.1% -65.5% 0.0% 0.0%   ROI %   58.9% 26.4% -61.3% 102.2% -20.7% -173.9% 0.0% 0.0%   ROE %   58.8% 17.4% -54.8% 73.7% -26.9% -128.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.1% 41.6% 23.9% 58.1% 59.3% 14.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -114.2% -175.2% 109.6% -84.6% 3,027.0% 40.8% 0.0% 0.0%   Gearing %   34.9% 33.1% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.7% 22.0% 31.1% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.7 1.6 0.7 1.6 1.7 0.9 0.0 0.0   Current Ratio   1.8 1.7 0.8 1.6 1.7 0.9 0.0 0.0   Cash and cash equivalent   212.4 137.4 38.1 75.0 35.6 34.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   132.8 72.1 -26.6 41.9 35.4 -5.8 -16.9 -16.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -35 89 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -35 89 0 0 0 0   EBIT / employee   0 0 -46 72 0 0 0 0   Net earnings / employee   0 0 -34 52 0 0 0 0